VOTIS Subdermal Imaging Technologies
Jerusalem
About VOTIS Subdermal Imaging Technologies
VOTIS Subdermal Imaging Technologies help diabetics keep their feet through early screening for peripheral vascular disease and related complications. Early screening can offer new treatment options and help reduce incidents of amputation. Their device is non-invasive and contact-free, not based on radiation, and functionally consistent with the guidelines of the AHA, the American Diabetes Association, and other leading medical organizations. It will reduce healthcare costs for hospitals, clinics, and insurers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.8M
- Funding stage: Seed
- Last round: Seed (Apr 2023)
- Website: votis.net
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/votis-subdermal-imaging-technologies-39220 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.